

5-Amino-1MQ 50mg is a research-grade nicotinamide N-methyltransferase (NNMT) inhibitor developed for laboratory investigations involving cellular metabolism, methylation biology, NAD⁺ metabolism, and metabolic signaling pathways. Every batch undergoes rigorous analytical verification to ensure purity, consistency, and reproducibility, making it suitable for advanced biochemical, molecular biology, and metabolic research applications.
HPLC certified
Independent analysis
Highest standard
Full traceability
5-Amino-1MQ 50mg is an investigational small-molecule research compound designed to selectively inhibit nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism, methyl donor utilization, and cellular metabolic regulation. Unlike peptide-based research compounds that primarily target cell-surface receptors, 5-Amino-1MQ enables researchers to investigate intracellular enzymatic activity, metabolic pathway regulation, NAD⁺ homeostasis, and epigenetic mechanisms under controlled laboratory conditions. Its distinct mechanism has established it as an important investigational compound within metabolic biology and enzyme research.
The 50mg presentation is particularly suited for laboratories conducting long-term biochemical investigations, enzyme inhibition studies, analytical method validation, metabolic pathway analysis, and high-throughput screening. Researchers continue evaluating NNMT inhibition, methylation dynamics, intracellular signaling, enzyme kinetics, and molecular regulation to better understand the biological role of NNMT within cellular metabolism. Manufactured according to research-grade quality standards and supported by comprehensive analytical verification, 5-Amino-1MQ 50mg provides laboratories with a dependable investigational compound for advanced metabolic and molecular research.
5-Amino-1MQ 50mg is a research-grade small molecule recognized as a selective nicotinamide N-methyltransferase (NNMT) inhibitor. Rather than functioning as a peptide receptor agonist, this investigational compound targets intracellular enzymatic activity associated with NNMT, allowing researchers to investigate cellular metabolism, nicotinamide regulation, methyl donor utilization, and metabolic signaling under controlled laboratory conditions. Its unique mechanism has established 5-Amino-1MQ as an important research tool within enzymology, metabolic biology, and molecular pharmacology.
NNMT is an intracellular enzyme responsible for catalyzing the methylation of nicotinamide using S-adenosyl-L-methionine (SAM) as a methyl donor, generating 1-methylnicotinamide (MNA) as a metabolic product. Because NNMT participates in nicotinamide metabolism and influences cellular methylation balance, researchers investigate how selective inhibition affects metabolic pathways, NAD⁺ homeostasis, methyl donor availability, and broader intracellular regulatory networks. These investigations continue expanding scientific understanding of enzyme-mediated metabolic regulation.
Current laboratory investigations examine the molecular interactions between 5-Amino-1MQ and the NNMT enzyme. Researchers study enzyme-binding affinity, inhibition kinetics, structural biology, substrate competition, catalytic activity, intracellular enzyme regulation, and downstream molecular responses following selective NNMT inhibition. These studies provide valuable insight into enzyme pharmacology and metabolic pathway regulation.
Scientific investigations also evaluate how NNMT inhibition influences interconnected metabolic systems. Research focuses on NAD⁺ metabolism, methylation pathways, one-carbon metabolism, nicotinamide recycling, cellular energy regulation, and epigenetic mechanisms that depend upon intracellular methyl donor availability. These investigations contribute to understanding complex biochemical networks while supporting the development of next-generation metabolic research models.
Comparative pharmacology represents another important application of 5-Amino-1MQ. Researchers frequently investigate this compound alongside NAD⁺ precursors, NMN (Nicotinamide Mononucleotide), Nicotinamide Riboside (NR), and other investigational compounds involved in metabolic regulation to better understand complementary mechanisms within nicotinamide metabolism and cellular bioenergetics. Rather than targeting receptor-mediated signaling, these investigations emphasize intracellular enzymatic regulation and biochemical pathway analysis.
The 50mg presentation is particularly appropriate for laboratories conducting extensive enzyme inhibition studies, metabolic pathway investigations, biochemical assays, analytical validation, compound screening, and collaborative research programs requiring increased compound availability. Although different package sizes may be available, the molecular identity, inhibitory mechanism, analytical quality standards, and scientific applications remain consistent across all 5-Amino-1MQ presentations.
Beyond enzyme biology, 5-Amino-1MQ serves as an important analytical reference compound for enzymology, analytical chemistry, metabolomics, molecular characterization, biomarker investigations, pharmacodynamic research, assay optimization, and high-throughput screening platforms. Its reproducible inhibitory profile and well-characterized molecular properties make it valuable for laboratories conducting advanced biochemical and molecular research.
Each batch of 5-Amino-1MQ 50mg is manufactured according to research-grade production standards and undergoes comprehensive analytical verification before release. Quality assurance procedures include High-Performance Liquid Chromatography (HPLC) purity analysis, molecular identity confirmation, and rigorous batch-specific quality control testing. These analytical measures support reproducibility, consistency, and confidence across independent laboratory investigations.
To preserve molecular integrity, 5-Amino-1MQ should be stored according to accepted laboratory recommendations for research chemicals. Appropriate storage conditions, controlled handling practices, and adherence to laboratory protocols help maintain compound stability before analytical evaluation and experimental use.
Although considerable progress has been made in understanding NNMT biology, scientific investigations continue exploring enzyme regulation, metabolic adaptation, epigenetic interactions, NAD⁺ metabolism, and intracellular signaling associated with selective NNMT inhibition. Consequently, 5-Amino-1MQ 50mg should be regarded as an investigational research compound intended exclusively to support laboratory research and scientific discovery.
5-Amino-1MQ 50mg is supplied exclusively for laboratory research and analytical applications. This product is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary applications, or diagnostic purposes.

Discover how NNMT and cellular metabolism connect to fat storage, NAD+ decline, and aging — and what current research says. Read the full breakdown.

Discover 5-Amino-1MQ: an NNMT inhibitor enhancing NAD+ metabolism, supporting fat oxidation, and improving cellular energy production. Complete metabolic research guide.

Semaglutide vs tirzepatide for weight loss — compare efficacy, side effects & cost using real clinical trial data. Read the full comparison now.
(faqs)